AUBERTON-HERVE ANDRE-JACQUES
Insider CIK 1730329 · BNKL Chairman, Director · CLAY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MOBX Chavant Capital Acquisitio | A Award deriv | 2023-12-21 | 2023-12-26 | 145,335 | — | $0 | 145,335 | SEC↗ |
| MOBX Chavant Capital Acquisitio | A Award | 2023-12-21 | 2023-12-26 | 198,049 | — | $0 | 540,966 | SEC↗ |
| MOBX Chavant Capital Acquisitio | A Award | 2023-12-21 | 2023-12-26 | 145,335 | $10.00 | $1.45M | 342,917 | SEC↗ |
| BNKL Bionik Laboratories Corp. | P Buy deriv | 2023-06-13 | 2023-06-21 | 1 | $220000.00 | $220.0K | 1 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2023-06-13 | 2023-06-21 | 186,111 | $0.60 | $111.7K | 1,109,271 | SEC↗ |
| BNKL Bionik Laboratories Corp. | P Buy | 2023-06-09 | 2023-06-21 | 650,000 | $0.60 | $390.0K | 923,160 | SEC↗ |
| CLAY Chavant Capital Acquisitio | D To issuer | 2022-02-24 | 2022-02-28 | 4,174 | — | $0 | 27,826 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise deriv | 2021-07-15 | 2022-06-21 | 51,878 | — | $0 | 63,881 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise deriv | 2021-07-15 | 2022-06-21 | 7,500 | — | $0 | 0 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise | 2021-07-15 | 2022-06-21 | 7,500 | $3.16 | $23.7K | 283,853 | SEC↗ |
| BNKL Bionik Laboratories Corp. | M Exercise | 2021-07-15 | 2022-06-21 | 51,878 | $3.60 | $186.8K | 276,353 | SEC↗ |
| BNKL Bionik Laboratories Corp. | P Buy | 2021-03-26 | 2021-04-01 | 95,149 | — | $0 | 95,149 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2019-07-26 | 2019-08-08 | 115,759 | — | $0 | 115,759 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2019-05-31 | 2019-06-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2019-03-28 | 2019-04-09 | 81,492 | $3.89 | $317.0K | 224,475 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-07-24 | 2018-07-26 | 6,688,480 | $0.05 | $334.4K | 21,447,183 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-06-13 | 2018-06-15 | 1,040,152 | $0.06 | $62.4K | 14,758,703 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-06-13 | 2018-06-15 | 1,039,115 | $0.06 | $62.3K | 14,758,703 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-03-31 | 2018-04-03 | 564,726 | $0.06 | $33.9K | 12,679,436 | SEC↗ |
| BNKL Bionik Laboratories Corp. | C Conversion | 2018-03-31 | 2018-04-03 | 12,114,710 | $0.06 | $726.9K | 12,679,436 | SEC↗ |
| BNKL Bionik Laboratories Corp. | A Award deriv | 2017-08-14 | 2018-04-03 | 1,600,640 | — | $0 | 1,600,640 | SEC↗ |